ENDONOVO THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

ENDONOVO THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $85.9 thousand for the year ending 2021.

  • ENDONOVO THERAPEUTICS, INC. showed an increase of +540.4% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from ENDONOVO THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on April 14, 2022.
  • XBRL data for this metric is available from 2009 to 2021 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2009 to 2021), ENDONOVO THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 74.5%.
  • Historical annual values: Fiscal year 2021: $85.9 thousand | Fiscal year 2020: $13.4 thousand | Fiscal year 2019: $18.9 thousand | Fiscal year 2018: $379.2 thousand | Fiscal year 2017: $90.2 thousand | Fiscal year 2016: $55.5 thousand | Fiscal year 2015: $41.5 thousand | Fiscal year 2014: $988.00 | Fiscal year 2013: $3.3 thousand | Fiscal year 2011: $69.7 thousand | Fiscal year 2010: $34.8 thousand | Fiscal year 2009: $49.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: